A detailed history of Savant Capital, LLC transactions in Cerus Corp stock. As of the latest transaction made, Savant Capital, LLC holds 117,688 shares of CERS stock, worth $190,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117,688
Previous 94,812 24.13%
Holding current value
$190,654
Previous $133,000 40.6%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$1.16 - $1.6 $26,536 - $36,601
22,876 Added 24.13%
117,688 $187,000
Q2 2025

Aug 06, 2025

BUY
$1.22 - $1.51 $89,357 - $110,598
73,244 Added 339.6%
94,812 $133,000
Q1 2025

May 08, 2025

BUY
$1.39 - $2.15 $29,979 - $46,371
21,568 New
21,568 $29,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.